Translational Control of Immune Evasion in Cancer
Mechanisms that control translation play important roles in tumor progression and metastasis. Emerging evidence has revealed that dysregulated translation also impacts immune evasion in response to cellular or oncogenic stress. Here, we summarize current knowledge regarding the translational control...
Gespeichert in:
| Veröffentlicht in: | Trends in Cancer 2021-07, Vol.7 (7), p.580-582 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 582 |
|---|---|
| container_issue | 7 |
| container_start_page | 580 |
| container_title | Trends in Cancer |
| container_volume | 7 |
| creator | Suresh, Shruthy O'Donnell, Kathryn A |
| description | Mechanisms that control translation play important roles in tumor progression and metastasis. Emerging evidence has revealed that dysregulated translation also impacts immune evasion in response to cellular or oncogenic stress. Here, we summarize current knowledge regarding the translational control of immune checkpoints and implications for cancer immunotherapies. |
| doi_str_mv | 10.1016/j.trecan.2021.04.002 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_33972197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33972197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-c8fb3aa86f58e8d9cd532a791c63e45e6b3fd8de4d998808fd591a399138b8c33</originalsourceid><addsrcrecordid>eNpVkNtKAzEURYMottT-gcj8wIy5T_IiyFAvUPClPodMLjplJinJtODfO6Va9Okc2Ox9zl4A3CJYIYj4_bYakzM6VBhiVEFaQYgvwBxTyEoBMbs874TMwDLnLYQQMY45ptdgRoisMZL1HKBN0iH3euxi0H3RxDCm2BfRF6_DsA-uWB10nrSiC0Wjg3HpBlx53We3_JkL8P602jQv5frt-bV5XJeGcjKWRviWaC24Z8IJK41lBOtaIsOJo8zxlngrrKNWSiGg8JZJpImUiIhWGEIW4OGUu9u3g7PGTZ_pXu1SN-j0paLu1H8ldJ_qIx6UmEqy-hhATwEmxZyT82cvgupIUW3ViaI6UlSQqoniZLv7e_ds-mVGvgFEj3Cg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Translational Control of Immune Evasion in Cancer</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Suresh, Shruthy ; O'Donnell, Kathryn A</creator><creatorcontrib>Suresh, Shruthy ; O'Donnell, Kathryn A</creatorcontrib><description>Mechanisms that control translation play important roles in tumor progression and metastasis. Emerging evidence has revealed that dysregulated translation also impacts immune evasion in response to cellular or oncogenic stress. Here, we summarize current knowledge regarding the translational control of immune checkpoints and implications for cancer immunotherapies.</description><identifier>ISSN: 2405-8033</identifier><identifier>EISSN: 2405-8025</identifier><identifier>DOI: 10.1016/j.trecan.2021.04.002</identifier><identifier>PMID: 33972197</identifier><language>eng</language><publisher>United States</publisher><subject>Disease Progression ; Eukaryotic Initiation Factors - metabolism ; Gene Expression Regulation, Neoplastic - drug effects ; Gene Expression Regulation, Neoplastic - immunology ; Humans ; Immune Checkpoint Inhibitors - pharmacology ; Immune Checkpoint Inhibitors - therapeutic use ; Immune Checkpoint Proteins - genetics ; Neoplasms - drug therapy ; Neoplasms - genetics ; Neoplasms - immunology ; Protein Biosynthesis - drug effects ; Protein Biosynthesis - immunology ; Tumor Escape - drug effects ; Tumor Escape - genetics</subject><ispartof>Trends in Cancer, 2021-07, Vol.7 (7), p.580-582</ispartof><rights>Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-c8fb3aa86f58e8d9cd532a791c63e45e6b3fd8de4d998808fd591a399138b8c33</citedby><cites>FETCH-LOGICAL-c463t-c8fb3aa86f58e8d9cd532a791c63e45e6b3fd8de4d998808fd591a399138b8c33</cites><orcidid>0000-0003-2215-1064</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33972197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suresh, Shruthy</creatorcontrib><creatorcontrib>O'Donnell, Kathryn A</creatorcontrib><title>Translational Control of Immune Evasion in Cancer</title><title>Trends in Cancer</title><addtitle>Trends Cancer</addtitle><description>Mechanisms that control translation play important roles in tumor progression and metastasis. Emerging evidence has revealed that dysregulated translation also impacts immune evasion in response to cellular or oncogenic stress. Here, we summarize current knowledge regarding the translational control of immune checkpoints and implications for cancer immunotherapies.</description><subject>Disease Progression</subject><subject>Eukaryotic Initiation Factors - metabolism</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Gene Expression Regulation, Neoplastic - immunology</subject><subject>Humans</subject><subject>Immune Checkpoint Inhibitors - pharmacology</subject><subject>Immune Checkpoint Inhibitors - therapeutic use</subject><subject>Immune Checkpoint Proteins - genetics</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - immunology</subject><subject>Protein Biosynthesis - drug effects</subject><subject>Protein Biosynthesis - immunology</subject><subject>Tumor Escape - drug effects</subject><subject>Tumor Escape - genetics</subject><issn>2405-8033</issn><issn>2405-8025</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkNtKAzEURYMottT-gcj8wIy5T_IiyFAvUPClPodMLjplJinJtODfO6Va9Okc2Ox9zl4A3CJYIYj4_bYakzM6VBhiVEFaQYgvwBxTyEoBMbs874TMwDLnLYQQMY45ptdgRoisMZL1HKBN0iH3euxi0H3RxDCm2BfRF6_DsA-uWB10nrSiC0Wjg3HpBlx53We3_JkL8P602jQv5frt-bV5XJeGcjKWRviWaC24Z8IJK41lBOtaIsOJo8zxlngrrKNWSiGg8JZJpImUiIhWGEIW4OGUu9u3g7PGTZ_pXu1SN-j0paLu1H8ldJ_qIx6UmEqy-hhATwEmxZyT82cvgupIUW3ViaI6UlSQqoniZLv7e_ds-mVGvgFEj3Cg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Suresh, Shruthy</creator><creator>O'Donnell, Kathryn A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2215-1064</orcidid></search><sort><creationdate>20210701</creationdate><title>Translational Control of Immune Evasion in Cancer</title><author>Suresh, Shruthy ; O'Donnell, Kathryn A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-c8fb3aa86f58e8d9cd532a791c63e45e6b3fd8de4d998808fd591a399138b8c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Disease Progression</topic><topic>Eukaryotic Initiation Factors - metabolism</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Gene Expression Regulation, Neoplastic - immunology</topic><topic>Humans</topic><topic>Immune Checkpoint Inhibitors - pharmacology</topic><topic>Immune Checkpoint Inhibitors - therapeutic use</topic><topic>Immune Checkpoint Proteins - genetics</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - immunology</topic><topic>Protein Biosynthesis - drug effects</topic><topic>Protein Biosynthesis - immunology</topic><topic>Tumor Escape - drug effects</topic><topic>Tumor Escape - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suresh, Shruthy</creatorcontrib><creatorcontrib>O'Donnell, Kathryn A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Trends in Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suresh, Shruthy</au><au>O'Donnell, Kathryn A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Translational Control of Immune Evasion in Cancer</atitle><jtitle>Trends in Cancer</jtitle><addtitle>Trends Cancer</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>7</volume><issue>7</issue><spage>580</spage><epage>582</epage><pages>580-582</pages><issn>2405-8033</issn><eissn>2405-8025</eissn><abstract>Mechanisms that control translation play important roles in tumor progression and metastasis. Emerging evidence has revealed that dysregulated translation also impacts immune evasion in response to cellular or oncogenic stress. Here, we summarize current knowledge regarding the translational control of immune checkpoints and implications for cancer immunotherapies.</abstract><cop>United States</cop><pmid>33972197</pmid><doi>10.1016/j.trecan.2021.04.002</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-2215-1064</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2405-8033 |
| ispartof | Trends in Cancer, 2021-07, Vol.7 (7), p.580-582 |
| issn | 2405-8033 2405-8025 |
| language | eng |
| recordid | cdi_pubmed_primary_33972197 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Disease Progression Eukaryotic Initiation Factors - metabolism Gene Expression Regulation, Neoplastic - drug effects Gene Expression Regulation, Neoplastic - immunology Humans Immune Checkpoint Inhibitors - pharmacology Immune Checkpoint Inhibitors - therapeutic use Immune Checkpoint Proteins - genetics Neoplasms - drug therapy Neoplasms - genetics Neoplasms - immunology Protein Biosynthesis - drug effects Protein Biosynthesis - immunology Tumor Escape - drug effects Tumor Escape - genetics |
| title | Translational Control of Immune Evasion in Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A42%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Translational%20Control%20of%20Immune%20Evasion%20in%20Cancer&rft.jtitle=Trends%20in%20Cancer&rft.au=Suresh,%20Shruthy&rft.date=2021-07-01&rft.volume=7&rft.issue=7&rft.spage=580&rft.epage=582&rft.pages=580-582&rft.issn=2405-8033&rft.eissn=2405-8025&rft_id=info:doi/10.1016/j.trecan.2021.04.002&rft_dat=%3Cpubmed_cross%3E33972197%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33972197&rfr_iscdi=true |